KTN's online platform helps you to make the connections you need


The Knowledge Transfer Network (KTN) has refreshed its online platform to intelligently connect you to relevant events, funding, thought pieces and specialist staff to help your business innovate and grow.

You can discover content using your area of interest, from Defence Security to transport; from space to health – all major UK economic sectors are covered. Once you have selected your interests, using our intelligent tagging system, we will then display rich and relevant content related to your area, often from surprising sources.

An example might be new satellite technology from the space sector that is applicable in the agri-food sector. KTN-UK.co.uk will help you form these unusual and valuable connections.

All content on the platform has been carefully curated by our team of innovation specialists – not by an automated algorithm – so you can be confident that KTN is connecting you to the most relevant cutting-edge information.


The move also marks a closer alignment with our main funder, Innovate UK , with the website branding making a clear visual link. Knowledge Transfer Network is Innovate UK's innovation network partner, and also works with other funders to provide innovation networking services and fulfil our mission to drive UK growth.

We link new ideas and opportunities with expertise, markets and finance through our network of businesses, universities, funders and investors. From agri-food to autonomous systems and from energy to design, KTN combines expertise in all sectors with the ability to cross boundaries. Connecting with KTN can lead to potential partners, horizon-expanding events and innovation insights relevant to your needs.

Visit our people pages to connect directly with expertise in your sector.

Visit the KTN refreshed online platfom here

« go back

Big Data for Better Outcomes Programme : Digital Health funding opportunity

Big Data for Better Outcomes Programme

CALL DEADLINE: 17th March 2016

Non-communicable diseases play a major role in the global burden of disease. By 2020, heart disease and stroke will become the leading causes of death and disability worldwide, with the number of fatalities projected to increase to more than 24 million by 2030.

Three common cardiovascular diseases - heart arrhythmias (primarily atrial fibrillation or AF), heart failure (HF) and acute coronary syndrome (ACS) – cause much of this disability.

While major advances in the management of these diseases have been achieved, medical management of these cardiovascular patients remains challenging. The need to improve awareness, risk assessment, diagnosis, and treatment is measureable.

The Innovative Medicines Initiative (IMI) is working to improve health by speeding up the development of, and patient access to, innovative medicines, particularly in areas where there is an unmet medical or social need. IMI is a partnership between the European Union (represented by the European Commission) and the European pharmaceutical industry (represented by EFPIA, the European Federation of Pharmaceutical Industries and Associations). Its remit has expanded in the most recent call and SME’s and those focused on health informatics in particular ‘BIG DATA’ are encouraged to investigate this opportunity through the new Big Data for Better Outcomes Programme.

The IMI2 Big Data for Better Outcomes (BD4BO) programme aims to catalyse and support the evolution towards value-based and more outcomes-focused sustainable and therefore better quality healthcare systems in Europe, exploiting the opportunities offered by the wealth of emerging data from many evolving data sources by generating methodologies and data that will inform policy debates. The programme’s objectives are to maximise the potential of large amounts of data from variable, quickly-developing digital and non-digital sources which will be referred to as ‘big data’ in the context of this initiative.


To Find out more about the BD4BO* programme, download the full Call 7 document here

(see topics 6 & 7, Page 51 onwards for a mixture of innovation funding and 'support actions')

Find out more about Call 7 here


Find out more about The Innovative Medicines Initiative here